# Kiperin Mind Focus supplement mitigates chronic stress–induced neuroinflammation and molecular dysregulation and improves stress-related affective and exploratory behaviors in rats

**Authors:** Lutfiye Karcioglu Batur, Cuneyd Yavas, Aysu Kilic, Tunay Dogan, Mert Yilmaz, Ahsen Pektas, Huri Demirci, Savas Ustunova

PMC · DOI: 10.3389/fnint.2025.1745274 · Frontiers in Integrative Neuroscience · 2026-01-29

## TL;DR

This study shows that Kiperin Mind Focus, a nootropic supplement, reduces stress-related brain inflammation and improves mood and behavior in stressed rats.

## Contribution

The study demonstrates the neuroprotective and behavioral benefits of a novel nootropic supplement in a chronic stress model.

## Key findings

- Kiperin Mind Focus reduced stress-induced anxiety, anhedonia, and behavioral despair in rats.
- The supplement normalized proinflammatory cytokines and oxidative stress markers in stressed rats.
- It attenuated stress-related gene dysregulation and reduced neuronal injury in the hippocampus and prefrontal cortex.

## Abstract

Chronic stress is known to impair emotional regulation and adaptive behavioral responses through neuroinflammatory activation, oxidative imbalance, and dysregulation of neuroplasticity-related genes. Kiperin Mind Focus, a nootropic nutraceutical containing L-theanine, citicoline, phosphatidylserine, Rhodiola rosea, Ginkgo biloba, caffeine, and Lion’s Mane mushroom extract has been formulated to support stress resilience, mood regulation and neural health. This study aimed to investigate the neuroprotective and neuroregulatory effects of the combined formulation on behavioral, biochemical, histopathological, and molecular parameters in rats exposed to chronic unpredictable mild stress (CUMS).

Thirty-two adult male Wistar rats were randomized into four groups (n = 8): Control, Stress, Kiperin Mind Focus (MF), and Stress + Mind Focus (SMF). CUMS was applied for 45 days, and the combined formulation was administered by oral gavage (130 mg/kg/day). Behavioral outcomes were evaluated using the sucrose preference (SPT), open field (OFT), elevated plus maze (EPM), and forced swim (FST) tests. Serum and tissue cytokine levels (IL-1β, IL-6, IL-10, TNF-α) and oxidative stress index (TOS/TAS ratio) were measured. Hippocampal and prefrontal gene expression of FOS, DBH, NMB, BDNF, CREB1, GRIN2A, and GABRB1 was assessed via qPCR, and histopathological changes were semi-quantitatively scored.

Chronic stress induced anhedonia, anxiety-like behavior, and behavioral despair, accompanied by elevated proinflammatory cytokines, oxidative imbalance, and neuronal degeneration in the hippocampus and prefrontal cortex. The supplementation significantly improved SPT, OFT, EPM, and FST performance, normalized cytokine and oxidative parameters, and reduced neuronal injury scores. At the molecular level, supplementation attenuated stress-induced upregulation of FOS, DBH, and NMB while maintaining neurotrophic (BDNF, CREB1) and GABAergic (GABRB1) expression near control levels.

Kiperin Mind Focus exerted robust neuroprotective, anti-inflammatory, and antioxidant effects under chronic stress, restoring molecular homeostasis and stabilizing stress-related behavioral outcomes. These findings support its role as a stress-buffering and mood-stabilizing supplement, that promotes emotional regulation and adaptive exploratory behavior under prolonged stress conditions.

## Linked entities

- **Genes:** FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353], DBH (dopamine beta-hydroxylase) [NCBI Gene 1621], NMB (neuromedin B) [NCBI Gene 4828], BDNF (brain derived neurotrophic factor) [NCBI Gene 627], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385], GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) [NCBI Gene 2903], GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1) [NCBI Gene 2560]
- **Chemicals:** L-theanine (PubChem CID 439378), citicoline (PubChem CID 13804), phosphatidylserine (PubChem CID 9547096), caffeine (PubChem CID 2519)

## Full-text entities

- **Genes:** Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Nmb (neuromedin B) [NCBI Gene 499194] {aka RGD1562710}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Grin2a (glutamate ionotropic receptor NMDA type subunit 2A) [NCBI Gene 24409] {aka GluN2A, NMDAR2A, NR2A}, Gabrb1 (gamma-aminobutyric acid type A receptor subunit beta1) [NCBI Gene 25450] {aka GARB1}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 314322] {aka c-fos}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Dbh (dopamine beta-hydroxylase) [NCBI Gene 25699] {aka DOPBHY}
- **Diseases:** neuronal degeneration (MESH:D009410), neuroinflammation (MESH:D000090862), anxiety (MESH:D001007), anhedonia (MESH:D059445), inflammatory (MESH:D007249)
- **Chemicals:** sucrose (MESH:D013395), phosphatidylserine (MESH:D010718), caffeine (MESH:D002110), citicoline (MESH:D003566), Focus (-), L-theanine (MESH:C026166), TAS (MESH:D013635)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Ginkgo biloba (ginkgo, species) [taxon 3311], Rhodiola rosea (rose-root, species) [taxon 203015]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12894388/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12894388/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12894388/full.md

---
Source: https://tomesphere.com/paper/PMC12894388